Purpura, Thrombocytopenic, Idiopathic: all 521 studies
Page 4 of 6. Open to participants first (158), then studies with results posted, then the rest; newest registration first within each.
- Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 MonthsWithdrawnNCT05046327Phase 3
- Phase III Study on HMPL-523 for Treatment of ITPCompletedNCT05029635Phase 3
- A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITPActive, not recruitingNCT05023915Phase 2
- A Clinical Trial of the Orelabrutinib in the Management of Refractory ITPStatus unknownNCT05020288Phase 2
- Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)Status unknownNCT04949009
- An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITPCompletedNCT04943042
- ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEaseCompletedNCT04912505Phase 2
- Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior TherapyTerminatedNCT04904276
- Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and InflammationCompletedNCT04902807
- Idiopathic Purpura Fulminans Associated With Anti-PS Antibodies in ChildrenCompletedNCT04845113
- A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune ThrombocytopeniaActive, not recruitingNCT04812925Phase 3
- Immunomodulation With Eltrombopag in ITPCompletedNCT04812483Phase 2
- The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaStatus unknownNCT04747080Phase 2
- Post IVIG Medication in Children With Immune ThrombocytopeniaStatus unknownNCT04741139Phase 1
- Hetrombopag for Pediatric Patients With Chronic Immune ThrombocytopeniaCompletedNCT04737850Phase 3
- Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITPStatus unknownNCT04735588
- A Study of ATRA in the Treatment of ITPStatus unknownNCT04618328Phase 2
- Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune ThrombocytopeniaStatus unknownNCT04588194Phase 2
- Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)Status unknownNCT04518878Phase 1
- Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)Status unknownNCT04516837Phase 2
- The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT04481282Phase 2
- The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITPStatus unknownNCT04368598Phase 2
- Connection Between Vitamin D Level and the Efficacy of Dexamethasone in Immune ThrombocytopeniaStatus unknownNCT04320225
- Prognostic Value of CD Markers in Immune Thrombocytopenic PurpuraStatus unknownNCT04311593
- Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune ThrombocytopeniaStatus unknownNCT04289207Phase 2
- A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)WithdrawnNCT04274452Phase 3
- A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).CompletedNCT04225156Phase 3
- The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaCompletedNCT04217148Phase 2
- Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?Status unknownNCT04128358Not applicable
- Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple TherapyStatus unknownNCT04113915
- Eltrombopag in Chronic ITPStatus unknownNCT04102033Phase 4
- Effect of DNMT SNPs on DNA Methylation in Primary ITPStatus unknownNCT04100876
- A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITPStatus unknownNCT04094805Phase 4
- Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)CompletedNCT04089267Phase 4
- Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic AnemiaCompletedNCT04083014Phase 2
- Diagnostic of Chronic ThrombocytopeniaCompletedNCT04071496
- National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.CompletedNCT04070612
- Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.CompletedNCT04070599Phase 3
- Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.CompletedNCT04057703
- Immunological Markers in Adult Patients With Immune Thrombocytopenic PurpuraCompletedNCT04056507
- A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITPWithdrawnNCT04039477Phase 2
- Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune ThrombocytopeniaCompletedNCT04014166Not applicable
- Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITPStatus unknownNCT03998982Phase 4
- Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE)Status unknownNCT03975361Not applicable
- Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune CytopeniaWithdrawnNCT03965624Phase 2
- The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia PatientsCompletedNCT03951623Phase 1
- Role of CD11a in Pathogenesis of Primary ITP and Effect of Immunosuppressive Therapy on Its LevelCompletedNCT03864796
- Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic PurpuraCompletedNCT03830749Phase 2
- Risk Factors for Thrombosis in Immune ThrombocytopeniaCompletedNCT03820960
- Association of Platelet Parameters With Bleeding Severity in Children With ITPCompletedNCT03810352
- Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)Status unknownNCT03771378Phase 4
- Atorvastatin in Management of Newly Diagnosed ITPStatus unknownNCT03692754Phase 2/3
- A Study to Evaluate Different Intervals Between Dosing and Feeding on the PharmacokineticsCompletedNCT03603132Phase 1
- Severe Immune Cytopenia Registry Www.Sic-reg.OrgCompletedNCT03576742
- Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune ThrombocytopeniaStatus unknownNCT03520049Phase 3
- Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune ThrombocytopeniaStatus unknownNCT03492515Phase 3
- Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)CompletedNCT03469661
- Investigation on a Dynamic Cohort of Italian Patients With Active ITPStatus unknownNCT03465020
- The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT03460808Phase 1/2
- Rituximab Combining Bortezomib Versus Rituximab in Management of ITPStatus unknownNCT03443570Phase 3
- French Adult Primary Immune ThrombocytopeniaStatus unknownNCT03429660
- Study of Platelets Sialylation by Flow Cytometry for the Differential Diagnosis of ICTCompletedNCT03421392
- Dietary Phytoestrogens as Risk Factors for Systemic Lupus ErythematosusCompletedNCT03421184Not applicable
- The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.CompletedNCT03412188Not applicable
- The Association Between Platelet Reactivity and Bleeding Risk in Adult ITPStatus unknownNCT03377439
- Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITPNo longer availableNCT03363334
- Evaluation of HRQoL in Adult With Immune Thrombocytopenia in ChinaStatus unknownNCT03324087
- The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT03304288Phase 2
- A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)CompletedNCT03275454Phase 1
- The Study of Different Dose Rituximab in the Treatment of ITPCompletedNCT03258866Phase 4
- Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITPStatus unknownNCT03252457Phase 3
- Lymphocyte Counts in Immune Thrombocytopenic PurpuraStatus unknownNCT03244410
- Reposition of Second Line Treatment in Chronic Immune ThrombocytopeniaCompletedNCT03229746Phase 4
- Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) PatientCompletedNCT03222843Phase 3
- The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune ThrombocytopeniaActive, not recruitingNCT03201848Phase 4
- Comparison Between Methyl Prednisolone and Intravenous Dexamethazone in Severe Immune Thrombocytopenic PurpraStatus unknownNCT03183284
- H. Pylori Eradication for Moderate ITPStatus unknownNCT03177629Phase 3
- Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic PurpuraStatus unknownNCT03172676Phase 4
- A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)CompletedNCT03164915Phase 3
- Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & MycophenolateCompletedNCT03156452Phase 3
- Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune ThrombocytopeniaCompletedNCT03154385Not applicable
- Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura (Kid's ITP Tools)Status unknownNCT03123497
- A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITPCompletedNCT03102593Phase 2
- Clinical Trial of Gut Microbiota in the Management of Immune ThrombocytopeniaStatus unknownNCT03033199Phase 2
- A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)Status unknownNCT03013114Phase 2
- The PROLONG Trial - Rituximab Maintenance Therapy in ITPCompletedNCT03010202Phase 3
- RP% Measurement by FCM as a Diagnostic Test for ITPStatus unknownNCT02967328
- Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With DexamethasoneCompletedNCT02914054Phase 2/3
- Immune Thrombocytopenia in PregnancyStatus unknownNCT02892630
- Regulatory B Cells and Chronic Immune ThrombocytopeniaCompletedNCT02891109
- Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP PatientsStatus unknownNCT02877212Phase 3
- Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)CompletedNCT02868099Phase 3
- Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)CompletedNCT02868060Phase 1/2
- This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)CompletedNCT02859909Phase 3
- DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP PatientsStatus unknownNCT02834468Phase 3
- Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune ThrombocytopeniaStatus unknownNCT02834286Phase 2
- Immunomodulation With Romiplostim in Young Adults With ITPCompletedNCT02760251Phase 4
- Treatment of ITP With Rituximab and / or AccutaneStatus unknownNCT02757196Phase 2
- Thrombocytopenia in Gestational PeriodStatus unknownNCT02751593Phase 2/3
- Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune ThrombocytopeniaWithdrawnNCT02649504Phase 3